Brief: Ensysce Biosciences- On Oct 27 Filed Amendment To Third Amended, Restated Certificate Of Incorporation To Effect 1-For-20 Reverse Stock Split Of Common Stock
Oct 28 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES- ON OCT 27 FILED AMENDMENT TO THIRD
AMENDED,
RESTATED CERTIFICATE OF INCORPORATION TO EFFECT 1-FOR-20 REVERSE
STOCK SPLIT OF COMMON STOCK
Source text for Eikon: [ID:https://bit.ly/3TQuPa7]
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing